FRE — Firebrick Pharma Cashflow Statement
0.000.00%
Last trade - 00:00
- AU$11.04m
- AU$9.73m
- AU$0.00m
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | -1.1 | -0.985 | -1.54 | -2.81 | -4.25 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | -1.06 | -0.985 | -1.94 | -4.2 | -5.78 |
Capital Expenditures | — | — | -0.016 | -0.033 | -0.002 |
Purchase of Fixed Assets | |||||
Cash from Investing Activities | — | — | -0.016 | -0.033 | -0.002 |
Financing Cash Flow Items | 0.572 | 0.092 | -0.116 | -0.474 | -0.006 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 1.26 | 0.5 | 3.01 | 10.2 | 0.997 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.195 | -0.485 | 1.06 | 5.99 | -4.79 |